Understanding the R&D Super-Deduction Framework

Foreign companies conducting qualifying R&D in China can claim a 100% super-deduction on eligible expenses as of 2026, effectively doubling the amount they can deduct from taxable income. The corporate income tax (CIT) super-deduction, governed by Caishui [2023] No. 7 and extended through 2027, allows enterprises to deduct 200% of qualifying R&D expenditure — meaning for every RMB 1 million spent on eligible R&D activities, RMB 2 million can be deducted from taxable income. For a company paying the standard 25% CIT rate, this translates to a tax saving of RMB 250,000 per million of qualifying spend. However, maximizing this benefit requires meticulous expense categorization, robust documentation, and strategic planning around the boundary between capitalizable and expense-type R&D.

Understanding the R&D Super-Deduction Framework

The R&D super-deduction (研发费用加计扣除, yánfā fèiyòng jiājì kòuchú) is China’s primary fiscal incentive for corporate innovation. First introduced in 2008 and progressively expanded, the current regime provides a 100% additional deduction (200% total) for qualifying R&D expenses incurred by resident enterprises. The policy applies to both domestic and foreign-invested enterprises (FIEs), provided the R&D activity meets the definition set out in the STA’s “Administrative Measures for the Additional Deduction of Enterprise R&D Expenses” (Guoshuifa [2023] No. 7).

China’s State Taxation Administration (国家税务总局, Guójiā Shuìwù Zǒngjú) and Ministry of Finance (财政部, cáizhèng bù) jointly administer the incentive. The key regulatory documents are Caishui [2023] No. 7, which extended the 100% super-deduction through December 31, 2027, and STA Announcement [2021] No. 28, which governs the filing and documentation process. As of 2026, the policy applies to all enterprises with qualifying R&D activities — there is no special application process, and the deduction is claimed through the annual CIT filing.

Qualifying R&D Activities: What Counts

Not every technical expenditure qualifies for the super-deduction. The STA defines qualifying R&D as “systematic and creative activities aimed at making discoveries, developing new products or processes, or substantially improving existing ones.” The definition explicitly excludes routine product testing, quality control, market research, and cosmetic modifications.

Qualifying activities fall into three broad categories:

• New product and process development — design, prototyping, pilot trials, and testing of completely new products or manufacturing processes. Example: developing a new EV battery chemistry from the lab scale through to production feasibility.
• Substantial improvement of existing products — significant upgrades that change core functionality, performance, or efficiency. Cosmetic changes or minor feature additions do not qualify. Example: redesigning a motor’s cooling system to reduce energy consumption by 15% or more.
• Technology transfer adaptation — adapting foreign-developed technology to Chinese production conditions, where the adaptation involves material technical risk and experimentation. Example: modifying a foreign chemical synthesis process to use Chinese-sourced precursor materials with different purity profiles.

Activities that explicitly do not qualify include: routine equipment calibration and maintenance, software bug fixes that do not change core functionality, market research and consumer surveys, routine data collection without experimental design, and social science research. The STA has published a negative list in Guoshuifa [2017] No. 39 — foreign companies should review this list carefully when categorizing expenses.

Six Categories of Deductible R&D Expenses

The super-deduction applies to six defined categories of expenditure, each with specific rules and documentation requirements. Proper categorization is the single most important factor in maximizing the deduction.

Note the critical distinction for outsourced R&D: domestic third-party R&D qualifies for the full 100% super-deduction, but cross-border outsourced R&D (i.e., R&D contracted to a related or unrelated party outside mainland China) is capped at 80% of the actual expenditure. This is governed by Caishui [2018] No. 64 and is a frequent source of audit adjustments for FIEs with global R&D networks.

Capitalizable vs. Expense-Type R&D: The Strategic Decision

One of the most consequential structural decisions is whether to capitalize R&D expenditure or treat it as an operating expense. Under PRC Enterprise Accounting Standard (EAS) No. 6 — Intangible Assets (企业会计准则第6号——无形资产), R&D costs must be bifurcated into two phases:

1. Research phase (研究阶段, yánjiū jiēduàn) — all expenses in this phase must be expensed as incurred, regardless of the project’s prospects. This is the default treatment and qualifies for the super-deduction in the year incurred.
2. Development phase (开发阶段, kāifā jiēduàn) — expenses can be capitalized as an intangible asset if the enterprise can demonstrate technical feasibility, intent to complete, ability to use or sell, future economic benefits, adequate resources to complete, and reliable measurement of attributable costs (EAS No. 6, Article 9). Capitalized costs are amortized over the asset’s useful life (typically 5–10 years for R&D intangibles) and the amortization amount also qualifies for the 100% super-deduction in each year it is recognized.

For FIEs maximizing the super-deduction, the general rule is: expense-type treatment produces faster tax benefits because the full deduction is available immediately rather than spread over the amortization period. However, capitalizing R&D can be advantageous when:

• The company expects higher tax rates in future years (making future deductions more valuable)
• The company has insufficient taxable income in the current year to absorb the full deduction (the unused portion can carry forward 10 years, but capitalization smooths the benefit)
• Transfer pricing considerations make it beneficial to capitalize intellectual property in a Chinese entity (adding asset value to the Chinese FIE for future royalty or exit planning)

Documentation Requirements: Defending Your Deduction

The STA requires R&D deduction claimants to prepare and retain a “Special Report on Additional Pre-Tax Deduction of R&D Expenses” (研发支出辅助账, yánfā zhīchū fǔzhù zhàng) — a subsidiary ledger that tracks R&D expenses by project and category. As of 2026, the following documentation must be available for tax inspection:

• Project plan — written description of the R&D project, objectives, milestones, budget, and timeline
• Staff allocation records — for shared personnel, time sheets showing hours spent on R&D vs. non-R&D activities
• Expense breakdowns — categorized subsidiary ledger with invoices, contracts, and payment records for each expense category
• Outsourcing contracts — for third-party R&D, the contract must specify the R&D scope, deliverables, and IP ownership
• Completion records — test reports, prototype documentation, patent filings, or technical acceptance certificates for completed projects

A critical compliance point: since the 2023 filing season, the STA has been using Golden Tax Phase IV (金税四期, Jīnshuì Sì Qī) data matching to cross-reference R&D deduction claims against patent filings, technology contract registrations, and social insurance records for R&D personnel. Companies claiming large deductions without corresponding technical outputs have seen audit rates increase substantially. In 2025, STA data showed adjustment rates of approximately 15% for R&D deduction claims, with the most common adjustments being disallowed personnel costs (37% of adjustments) and improperly categorized outsourced R&D (28%).

Strategic Expense Categorization: Maximizing the Claim

Within the six permitted categories, FIEs have several legitimate strategies to maximize their super-deduction without running afoul of the rules:

Personnel Cost Optimization

Personnel costs are typically the largest R&D expense category, representing 50–70% of total qualifying expenditure for most technology companies. Two structural strategies can increase this component:

1. Time allocation for dual-role staff. Engineers who split time between R&D and production support should keep detailed time sheets. The STA permits proportional allocation based on contemporaneous time records. A common target is to allocate 60–80% of senior engineer time to R&D activities, supported by project-specific time sheets signed by both the employee and project manager.

2. Bonus and incentive structuring. Performance bonuses linked to R&D milestones (patent filings, prototype completion, technical reports) can be included in R&D personnel costs provided the bonus scheme is documented in employment contracts and the bonus payment records identify the specific R&D achievement. General annual bonuses without project linkage are not deductible under the super-deduction.

Outsourced R&D: Domestic vs. Cross-Border Planning

For FIEs with global R&D networks, the 80% cap on cross-border outsourced R&D creates a strong incentive to bring R&D activities into China. Consider the following comparison:

The RMB 100,000 tax saving difference between domestic and cross-border outsourcing for a RMB 2 million project often justifies the operational cost of establishing or expanding a local R&D team in China. Additionally, in-house R&D offers the flexibility to allocate personnel costs (the largest deductible category) more broadly than outsourced contracts.

Regional Variations and Additional Incentives

Certain regions in China offer enhanced R&D incentives that stack with the national super-deduction:

For example, a foreign company establishing an R&D center in Lingang (Shanghai FTZ) that qualifies for both the 15% CIT rate and the 100% super-deduction could achieve an effective tax rate of approximately 7.5% on qualifying R&D profits — the result of applying the 15% rate to income reduced by 200% deduction for R&D spend. This combined effect can make China one of the most tax-efficient R&D locations globally.

Common Compliance Pitfalls and How to Avoid Them

Foreign companies face several recurring audit risks when claiming the R&D super-deduction:

• Mixing R&D and production assets — Equipment used for both R&D and production must be allocated based on usage hours. Allocate 100% to R&D only if the equipment is used exclusively for R&D projects. A 2024 inspection in Shanghai found that 23% of FIE audit adjustments involved improperly claimed depreciation on dual-use equipment.
• Outsourced R&D documentation gaps — Cross-border R&D contracts must include detailed scope of work, deliverables timeline, IP ownership terms, and cost breakdown. Generic service agreements without R&D-specific language routinely result in full disallowance.
• Failing to file the special auxiliary ledger — The R&D expense subsidiary ledger (研发支出辅助账) must be filed with the annual CIT return. Since 2023, the e-filing system (电子税务局) rejects returns with R&D claims if the ledger is not attached. Incomplete ledger filings were the second most common adjustment trigger in 2025.
• Over-including indirect costs — Management overhead, administrative support, and general facilities costs do not qualify. Only project-specific “other direct costs” such as travel, patent filing, and registration fees directly attributable to the R&D project are eligible.

R&D Super-Deduction Quick-Reference Checklist

Follow this ordered checklist to ensure your 2026 CIT filing maximizes the super-deduction while maintaining full compliance:

1. Audit all R&D projects — Review each project against the STA’s qualifying activity definition (Guoshuifa [2023] No. 7). Document the technical objective, novelty, and experimental methodology for each project before allocating expenses.
2. Prepare project-level subsidiary ledgers — Create the R&D expense auxiliary ledger (研发支出辅助账) for each project, with expenses categorized into the six permitted types. Ensure invoices, contracts, and payment records match the ledger entries.
3. Implement time tracking for R&D personnel — Deploy a time-recording system for R&D and dual-role staff. Time sheets must be signed contemporaneously — retroactive time allocation is not accepted under STA guidelines issued in 2023.
4. Separate R&D from production assets — Tag equipment used in R&D with asset codes. Calculate depreciation allocation percentages based on actual usage logs where equipment serves both functions.
5. Review outsourced R&D contracts — Verify that third-party R&D agreements contain specific technical scope, deliverables, and IP ownership clauses. For cross-border contracts, calculate the deduction at 80% of expenditure.
6. Maximize domestic R&D — Evaluate whether expanding Chinese R&D headcount or engaging domestic third-party labs improves the deduction versus cross-border outsourcing (where only 80% qualifies).
7. File the auxiliary ledger with the annual return — Attach the project-level R&D expense summary to the CIT annual filing. The e-filing system (https://etax.chinatax.gov.cn) requires this as a mandatory attachment for super-deduction claims.
8. Retain all supporting documents for 10 years — STA guidelines require taxpayers to retain R&D documentation for 10 years from the year of deduction. This includes project plans, time sheets, contracts, invoices, and completion reports.

Where to Go From Here

Based on what you just read:

• Ready to act? Read [guide: SLUG-TO-BE-FILLED]
• Still comparing? See [comparison: SLUG-TO-BE-FILLED]
• Need numbers? Try [tool: SLUG-TO-BE-FILLED]

— China Gateway 360 —
Remote China market entry support, built around execution.